82 FR 42824 - National Institute on Aging; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 175 (September 12, 2017)

Page Range		42824-42825
FR Document		2017-19231

Federal Register, Volume 82 Issue 175 (Tuesday, September 12, 2017)

[Federal Register Volume 82, Number 175 (Tuesday, September 12, 2017)]
[Notices]
[Pages 42824-42825]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-19231]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Aging Special Emphasis 
Panel; Resource Centers for Minority Aging Research (RCMAR) ZAG1 
ZIJ-9 J1.
    Date: October 31-November 1, 2017.
    Time: 5:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 
Bethesda, MD 20814.
    Contact Person: Carmen Moten, Ph.D., MPH, Scientific Review 
Officer, National Institute on Aging, Gateway Building, 7201 
Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301-402-7703, 
[email protected].

    Name of Committee: National Institute on Aging Special Emphasis 
Panel; Resource Centers for Minority Aging Research (RCMAR) ZAG1 
ZIJ-9 J3.
    Date: October 31-November 1, 2017.
    Time: 5:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 
Bethesda, MD 20814.
    Contact Person: Carmen Moten, Ph.D., MPH, Scientific Review 
Officer, National Institute on Aging, Gateway Building, 7201 
Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301-402-7703, 
[email protected].


[[Page 42825]]


    Name of Committee: National Institute on Aging Special Emphasis 
Panel; Resource Centers for Minority Aging Research (RCMAR) ZAG1 
ZIJ-9 J2.
    Date: October 31-November 1, 2017.
    Time: 5:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 
Bethesda, MD 20814.
    Contact Person: Carmen Moten, Ph.D., MPH, Scientific Review 
Officer, National Institute on Aging, Gateway Building, 7201 
Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301-402-7703, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)

    Dated: September 6, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-19231 Filed 9-11-17; 8:45 am]
 BILLING CODE 4140-01-P

42824 Federal Register / Vol. 82, No. 175 / Tuesday, September 12, 2017 / Notices

high affinity for plasma albumin and provisions set forth in sections MSC 7818, Bethesda, MD 20892, 301–435–
has been used for a long time in clinical 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 1198, sahaia@csr.nih.gov.
practice for determination of patient as amended. The grant applications and (Catalogue of Federal Domestic Assistance
plasma volume. The current imaging the discussions could disclose Program Nos. 93.306, Comparative Medicine;
agent is a truncated form of EB [NEB]) confidential trade secrets or commercial 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
and has the ability to bind albumin with property such as patentable material, 93.846–93.878, 93.892, 93.893, National
high affinity. The agent is also and personal information concerning Institutes of Health, HHS)
conjugated to NOTA to enable in vivo individuals associated with the grant
Dated: September 6, 2017.
labeling with 18F labeling by the applications, the disclosure of which
formation of 18F-aluminum fluoride would constitute a clearly unwarranted Natasha M. Copeland,
complex. The NOTA also facilitates invasion of personal privacy. Program Analyst, Office of Federal Advisory
Committee Policy.
radiometal labeling of NEB with either Name of Committee: Center for Scientific
68Ga or 64Cu. The resulting imaging [FR Doc. 2017–19230 Filed 9–11–17; 8:45 am]
Review Special Emphasis Panel; Shared
agent does not affect the in vivo Instrumentation Grants for Flow Cytometers. BILLING CODE 4140–01–P

behavior of serum albumin such as Date: September 26, 2017.
circulation, extra-vascularization, and Time: 11:00 a.m. to 5:00 p.m.
turn-over; thus the imaging results will Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND
reflect the distribution and metabolism applications. HUMAN SERVICES
Place: National Institutes of Health, 6701
of serum albumin accurately. Rockledge Drive, Bethesda, MD 20892 National Institutes of Health
Potential Commercial Applications: (Virtual Meeting).
• Blood pool imaging. Contact Person: Jonathan Arias, Ph.D., National Institute on Aging; Notice of
• Lymphatic system imaging. Scientific Review Officer, Center for Closed Meetings
Development Stage: Scientific Review, National Institutes of
• In vivo data available. Health, 6701 Rockledge Drive, Room 5170, Pursuant to section 10(d) of the
Inventors: Xiaoyuan Chen, Lixin Lang, MSC 7840, Bethesda, MD 20892, 301–435– Federal Advisory Committee Act, as
Gang Niu (all of NIBIB). 2406, ariasj@csr.nih.gov. amended, notice is hereby given of the
Intellectual Property: HHS Reference Name of Committee: Center for Scientific following meetings.
No. E–099–2015/0–US–01 and/0–US– Review Special Emphasis Panel; Shared and The meetings will be closed to the
02. High-End Mass Spectrometers. public in accordance with the
Date: September 28–29, 2017. provisions set forth in sections
• U.S. Patent Applications Time: 8:00 a.m. to 6:00 p.m.
14/675,364 filed March 31, 2015 and 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Agenda: To review and evaluate grant as amended. The grant applications and
15/587,948 filed May 5, 2017. applications.
Licensing Contact: Michael the discussions could disclose
Place: National Institutes of Health, 6701
Shmilovich, Esq, CLP; 301–435–5019; Rockledge Drive, Bethesda, MD 20892 confidential trade secrets or commercial
shmilovm@nih.gov. (Virtual Meeting). property such as patentable material,
Collaborative Research Opportunity: Contact Person: Sudha Veeraraghavan, and personal information concerning
The National Institute of Environmental Ph.D., Scientific Review Officer, Center for individuals associated with the grant
Health Sciences seeks statements of Scientific Review, National Institutes of applications, the disclosure of which
Health, 6701 Rockledge Drive, Bethesda, MD would constitute a clearly unwarranted
capability or interest from parties 20892, 301–435–1504,
interested in collaborative research to invasion of personal privacy.
sudha.veeraraghavan@nih.gov.
further develop and evaluate, please Name of Committee: National Institute on
Name of Committee: Healthcare Delivery
contact Cecilia Pazman, Office of Aging Special Emphasis Panel; Resource
and Methodologies Integrated Review Group;
Technology Transfer, National Heart, Centers for Minority Aging Research
Nursing and Related Clinical Sciences Study
(RCMAR) ZAG1 ZIJ–9 J1.
Lung and Blood Institute, pazmance@ Section.
Date: October 31–November 1, 2017.
nhlbi.nih.gov, 301–594–4273. Date: October 2–3, 2017.
Time: 5:00 p.m. to 4:00 p.m.
Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant
Dated: September 7, 2017. Agenda: To review and evaluate grant
Michael Shmilovich, applications.
applications. Place: Hyatt Regency Bethesda, One
Senior Licensing and Patenting Manager, Place: Embassy Suites at the Chevy Chase Bethesda Metro Center, Bethesda, MD 20814.
National Heart, Lung, and Blood Institute, Pavilion, 4300 Military Road NW., Contact Person: Carmen Moten, Ph.D.,
Office of Technology Transfer and Washington, DC 20015. MPH, Scientific Review Officer, National
Development. Contact Person: Rafael Semansky, Ph.D., Institute on Aging, Gateway Building, 7201
[FR Doc. 2017–19313 Filed 9–11–17; 8:45 am] Scientific Review Officer, Center for Wisconsin Avenue, Suite 2C212, Bethesda,
Scientific Review, National Institutes of MD 20892, 301–402–7703, cmoten@
BILLING CODE 4140–01–P
Health, 6701 Rockledge Drive, Room 2040M, mail.nih.gov.
Bethesda, MD 20892, 301–496–5749,
semanskyrm@csr.nih.gov. Name of Committee: National Institute on
DEPARTMENT OF HEALTH AND Aging Special Emphasis Panel; Resource
Name of Committee: Center for Scientific Centers for Minority Aging Research
HUMAN SERVICES Review Special Emphasis Panel; Clinical (RCMAR) ZAG1 ZIJ–9 J3.
Studies in Kidney Diseases (PAR–15–161). Date: October 31–November 1, 2017.
National Institutes of Health Date: October 2, 2017. Time: 5:00 p.m. to 4:00 p.m.
Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant
Center for Scientific Review; Notice of
pmangrum on DSK3GDR082PROD with NOTICES1

Agenda: To review and evaluate grant applications.
Closed Meetings applications. Place: Hyatt Regency Bethesda, One
Place: National Institutes of Health, 6701 Bethesda Metro Center, Bethesda, MD 20814.
Pursuant to section 10(d) of the
Rockledge Drive, Bethesda, MD 20892 Contact Person: Carmen Moten, Ph.D.,
Federal Advisory Committee Act, as (Telephone Conference Call). MPH, Scientific Review Officer, National
amended, notice is hereby given of the Contact Person: Atul Sahai, Ph.D., Institute on Aging, Gateway Building, 7201
following meetings. Scientific Review Officer, Center for Wisconsin Avenue, Suite 2C212, Bethesda,
The meetings will be closed to the Scientific Review, National Institutes of MD 20892, 301–402–7703, cmoten@
public in accordance with the Health, 6701 Rockledge Drive, Room 2188, mail.nih.gov.

VerDate Sep<11>2014 15:19 Sep 11, 2017 Jkt 241001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\12SEN1.SGM 12SEN1

Federal Register / Vol. 82, No. 175 / Tuesday, September 12, 2017 / Notices 42825

Name of Committee: National Institute on Addiction Research Programs, National programmatic requirements conveyed in
Aging Special Emphasis Panel; Resource Institutes of Health, HHS). TI–15–004, Cooperative Agreements for
Centers for Minority Aging Research SYT–I and TI–17–002, Cooperative
Dated: September 6, 2017.
(RCMAR) ZAG1 ZIJ–9 J2. Agreements for YT–I.
Date: October 31–November 1, 2017. Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
The purpose of this program is to
Time: 5:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant Committee Policy. provide funding to States/Territories/
applications. [FR Doc. 2017–19233 Filed 9–11–17; 8:45 am]
Tribes to improve treatment for
Place: Hyatt Regency Bethesda, One adolescents and transitional age youth
BILLING CODE 4140–01–P
Bethesda Metro Center, Bethesda, MD 20814. through the development of a learning
Contact Person: Carmen Moten, Ph.D., laboratory with collaborating local
MPH, Scientific Review Officer, National community-based treatment provider
Institute on Aging, Gateway Building, 7201 DEPARTMENT OF HEALTH AND
HUMAN SERVICES sites. Through the shared experience
Wisconsin Avenue, Suite 2C212, Bethesda, between the State/Territory/Tribe and
MD 20892, 301–402–7703, cmoten@
mail.nih.gov. Substance Abuse and Mental Health the local community-based treatment
Services Administration provider sites, an evidence-based
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
practice (EBP) will be implemented,
National Institutes of Health, HHS) Agency Information Collection youth and families will be provided
Activities: Submission for OMB services, and a feedback loop will be
Dated: September 6, 2017. developed to enable the State/Territory/
Review; Comment Request
Melanie J. Pantoja, Tribe and the sites to identify barriers
Program Analyst, Office of Federal Advisory Periodically, the Substance Abuse and and test solutions through a services
Committee Policy. Mental Health Services Administration component operating in real time. The
[FR Doc. 2017–19231 Filed 9–11–17; 8:45 am] (SAMHSA) will publish a summary of expected outcomes of these cooperative
BILLING CODE 4140–01–P
information collection requests under agreements will include needed changes
OMB review, in compliance with the to State/Territorial/Tribal policies and
Paperwork Reduction Act (44 U.S.C. procedures; development of financing
DEPARTMENT OF HEALTH AND Chapter 35). To request a copy of these structures that work in the current
HUMAN SERVICES documents, call the SAMHSA Reports environment; and a blueprint for States/
Clearance Officer on (240) 276–1243. Territories/Tribes and providers that
National Institutes of Health can be used throughout the State/
Project: Biannual Infrastructure
Development Measures for State Territory/Tribe to widen the use of
National Institute on Drug Abuse;
Adolescent and Transitional Aged effective substance use treatment EBPs.
Notice of Closed Meeting Additionally, adolescents (ages 12 to
Youth Treatment Enhancement and
Pursuant to section 10(d) of the Dissemination Implementation (SYT–I) 18), transitional age youth (ages 18 to
Federal Advisory Committee Act, as and Adolescent and Transitional Aged 24), and their families/primary
amended, notice is hereby given of the Youth Treatment Implementation (YT– caregivers who are provided services
following meeting. I) Programs—(OMB No. 0930–0344)— through grant funds will inform the
The meeting will be closed to the Revision process to improve systems issues.
public in accordance with the Estimates for response burden were
provisions set forth in sections The Substance Abuse and Mental calculated based on the methodology
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Health Services Administration (survey data collection) being used and
as amended. The contract proposals and (SAMHSA), Center for Substance Abuse are based on previous experience
the discussions could disclose Treatment has developed a set of collecting similar data and results of the
confidential trade secrets or commercial infrastructure development measures in pilot study. For emailed biannual
property such as patentable material, which recipients of cooperative surveys, burden estimates of 12.0 hours
and personal information concerning agreements will report on various were used for Project Directors and/or
individuals associated with the contract benchmarks on a semi-annual basis. The Program Managers and burden estimates
proposals, the disclosure of which infrastructure development measures of 7.2 hours were used for other project
would constitute a clearly unwarranted are designed to collect information at staff members. It is estimated that 11
invasion of personal privacy. the state-level and site-level. Project Directors and/or Program
The projects were previously named Managers and 22 other staff members
Name of Committee: National Institute on State Adolescent Treatment from Cohort 1 will respond to the
Drug Abuse Special Emphasis Panel;
Enhancement and Dissemination (SAT– emailed survey biannually (i.e., twice
Products to Prevent (Lethal) Drug-induced
Respiratory Depression (8942). ED) and State Youth Treatment each year) for 3 years at an estimated
Date: September 26, 2017. Enhancement and Dissemination (SYT– total burden of 1,742.4 hours for Cohort
Time: 10:00 a.m. to 12:00 p.m. ED) Programs and are now called State 1. It is estimated that 2 Project Directors
Agenda: To review and evaluate contract Adolescent And Transitional Aged and/or Program Managers and 4 other
proposals. Youth Treatment Enhancement and staff members from Cohort 2 will
Place: National Institutes of Health, Dissemination Implementation (SYT–I) respond to the emailed survey
Neuroscience Center, 6001 Executive and Adolescent and Transitional Aged biannually (i.e., twice each year) for 3
Boulevard, Rockville, MD 20852 (Telephone Youth Treatment Implementation (YT–I) years at an estimated total burden of
pmangrum on DSK3GDR082PROD with NOTICES1

Conference Call).
Programs. 316.8 hours for Cohort 2. It is estimated
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
No changes have been made to the that 11 Project Directors and/or Program
National Institute on Drug Abuse, NIH, Biannual Infrastructure Development Managers and 22 other staff members
DHHS, Room 4227, MSC 9550, 6001 Measures Report. The only revision to from Cohort 3 will respond to the
Executive Boulevard, Bethesda, MD 20892– the biannual progress report is due to emailed survey biannually (i.e., twice
9550, (301) 827–5702, lf33c.nih.gov. the decrease in the number of each year) for 3 years at an estimated
(Catalogue of Federal Domestic Assistance respondents. The infrastructure total burden of 1,742.4 hours for Cohort
Program No.: 93.279, Drug Abuse and development measures are based on the 3. The burden hours of Cohort 1 (1,742.4

VerDate Sep<11>2014 15:19 Sep 11, 2017 Jkt 241001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\12SEN1.SGM 12SEN1

Document Created: 2018-10-24 14:15:07
Document Modified: 2018-10-24 14:15:07

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		October 31-November 1, 2017.
FR Citation		82 FR 42824

82 FR 42824 - National Institute on Aging; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 175 (September 12, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health